The toxicology of aflatoxins as a basis for public health decisions

被引:323
作者
Wild, CP [1 ]
Turner, PC [1 ]
机构
[1] Univ Leeds, Sch Med, Mol Epidemiol Unit, Leeds LS2 9JT, W Yorkshire, England
关键词
D O I
10.1093/mutage/17.6.471
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Aflatoxins have been extensively studied with respect to their mechanisms of toxicity. An understanding of metabolism, DNA adduct induction, mutagenicity and carcinogenicity has been paralleled by the development of biomarkers of aflatoxin exposure and biological effects (e.g. mutations) applied to human populations. The improvements in exposure assessment and their application in prospective epidemiological studies and the demonstration of a specific mutation in the TP53 gene in hepatocellular carcinomas from areas of high aflatoxin exposure have contributed significantly to the classification of aflatoxins as human carcinogens. In addition to establishing the carcinogenicity of aflatoxins in humans, understanding molecular mechanisms of action has provided the scientific rationale for prevention strategies, including primary and chemoprevention approaches. Overall, integrated, multidisciplinary research on aflatoxins has provided the platform on which to base decisions regarding acceptable exposures and priorities for interventions to reduce human risk in a public health context.
引用
收藏
页码:471 / 481
页数:11
相关论文
共 170 条
[81]   cDNA cloning, expression and activity of a second human aflatoxin B1-metabolizing member of the aldo-keto reductase superfamily, AKR7A3 [J].
Knight, LP ;
Primiano, T ;
Groopman, JD ;
Kensler, TW ;
Sutter, TR .
CARCINOGENESIS, 1999, 20 (07) :1215-1223
[82]   An intercalation inhibitor altering the target selectivity of DNA damaging agents: Synthesis of site-specific aflatoxin B-1 adducts in a p53 mutational hotspot [J].
Kobertz, WR ;
Wang, D ;
Wogan, GN ;
Essigmann, JM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (18) :9579-9584
[83]   AFLATOXIN B1-ADDUCT FORMATION IN RAT AND HUMAN SMALL-BOWEL ENTEROCYTES [J].
KOLARS, JC ;
BENEDICT, P ;
SCHMIEDLINREN, P ;
WATKINS, PB .
GASTROENTEROLOGY, 1994, 106 (02) :433-439
[84]   GENETIC CHANGES AND HISTOPATHOLOGICAL GRADES IN HUMAN HEPATOCELLULAR CARCINOMAS [J].
KONISHI, M ;
KIKUCHIYANOSHITA, R ;
TANAKA, K ;
SATO, C ;
TSURUTA, K ;
MAEDA, Y ;
KOIKE, M ;
TANAKA, S ;
NAKAMURA, Y ;
HATTORI, N ;
MIYAKI, M .
JAPANESE JOURNAL OF CANCER RESEARCH, 1993, 84 (08) :893-899
[85]  
Koulibaly M, 1997, INT J CANCER, V70, P39, DOI 10.1002/(SICI)1097-0215(19970106)70:1&lt
[86]  
39::AID-IJC6&gt
[87]  
3.0.CO
[88]  
2-7
[89]  
KRESS S, 1992, CANCER RES, V52, P3220
[90]   LOW INCIDENCE OF P53 MUTATIONS IN EUROPEAN HEPATOCELLULAR CARCINOMAS WITH HETEROGENEOUS MUTATION AS A RARE EVENT [J].
KUBICKA, S ;
TRAUTWEIN, C ;
SCHREM, H ;
TILLMANN, H ;
MANNS, M .
JOURNAL OF HEPATOLOGY, 1995, 23 (04) :412-419